FAQ
Built multiple sets of modular, multi-functional intelligent drug automatic synthesis platform
The company's main business is the research and development and sales of drug synthesis systems
The company's main business is the research and sales of drug synthesis systems. It has built multiple modular and multifunctional intelligent drug fully automatic synthesis platforms, which can efficiently and stably complete the high-throughput preparation of drugs with different synthesis paths and meet strict clinical quality control requirements.
Developed various new nuclide labeled positron emission tomography tracers
We have developed a variety of new nuclide labeled positron emission tomography tracers (such as 18F-Safranamide, 18F-FHBG, 18F-MK9470, etc.) with high application value in the mechanism research and diagnosis of major diseases such as tumors, cardiovascular and cerebrovascular diseases, and neurodegeneration.
Brand value gradually forms an impact in the field of medical imaging
Hangzhou Jirui Technology Co., Ltd., established in September 2018, is a small and micro enterprise with brand value gradually forming an impact in the field of medical imaging. The company's main business is the research and development and sales of drug synthesis systems
©2024 Hangzhou Jirui Technology Co., Ltd. All Rights Reserved
Business License